Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
Beshara Sheehan, Antje Neeb, Lorenzo Buroni, et al.
The Journal of Clinical Investigation
|
April 1, 2026
Splicing factor TRA2B enhances synthesis of androgen receptor variant AR-V7 in prostate cancer cells
Nicholas Brittain, Alec Paschalis, Ryan Nelson, et al.
European Urology
|
October 21, 2018
Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
Zafeiris Zafeiriou, Diletta Bianchini, Robert Chandler, et al.
European Urology
|
July 27, 2019
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
Alec Paschalis, Beshara Sheehan, Ruth Riisnaes, et al.
The Journal of Clinical Investigation
|
September 26, 2023
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer
Beth Adamson, Nicholas Brittain, Laura Walker, et al.
European Urology
|
July 13, 2020
Elucidating Durable Responses to Immune Checkpoint Inhibition
Pasquale Rescigno, Caterina Aversa, Mateus Crespo, et al.
The Journal of Clinical Investigation
|
April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
Alec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
The Journal of Clinical Investigation
|
April 29, 2020
The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer
Susmita G Ramanand, Yong Chen, Jiapei Yuan, et al.
European Urology Oncology
|
March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer
Rafael Grochot, Christina Guo, Suzanne Carreira, et al.
Nature Medicine
|
June 27, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial
Susana Banerjee, Matthew G Krebs, Alastair Greystoke, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
Beshara Sheehan, Antje Neeb, Lorenzo Buroni, et al.
The Journal of Clinical Investigation
|
April 1, 2026
Splicing factor TRA2B enhances synthesis of androgen receptor variant AR-V7 in prostate cancer cells
Nicholas Brittain, Alec Paschalis, Ryan Nelson, et al.
European Urology
|
October 21, 2018
Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
Zafeiris Zafeiriou, Diletta Bianchini, Robert Chandler, et al.
European Urology
|
July 27, 2019
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
Alec Paschalis, Beshara Sheehan, Ruth Riisnaes, et al.
The Journal of Clinical Investigation
|
September 26, 2023
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer
Beth Adamson, Nicholas Brittain, Laura Walker, et al.
European Urology
|
July 13, 2020
Elucidating Durable Responses to Immune Checkpoint Inhibition
Pasquale Rescigno, Caterina Aversa, Mateus Crespo, et al.
The Journal of Clinical Investigation
|
April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
Alec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
The Journal of Clinical Investigation
|
April 29, 2020
The landscape of RNA polymerase II-associated chromatin interactions in prostate cancer
Susmita G Ramanand, Yong Chen, Jiapei Yuan, et al.
European Urology Oncology
|
March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer
Rafael Grochot, Christina Guo, Suzanne Carreira, et al.
Nature Medicine
|
June 27, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial
Susana Banerjee, Matthew G Krebs, Alastair Greystoke, et al.
Page
of 4